As part of the framework for collaboration, delegations of EUnetHTA and EFPIA representatives met on 5 November 2013 to discuss the pilots of relative effectiveness assessment. The minutes of this meeting are available both here on EUnetHTA's website and on EFPIA's website.
On 16 January, 2014, the first JA2 WP2 f-t-f training course for EUnetHTA Stakeholders took place. Agenda and presentations from the training are available in the OUTPUT section. Read more about Work Package 2 Read more about the EUnetHTA Stakeholder Forum
EUnetHTA Training Course for Stakeholders, Rome, 29 Oct 2014 Agenda EUnetHTA – The European network for Health Technology Assessment. Marianne Klemp, Research Director, NOKC, Norway See the presentation Key principles of HTA or What is Meant by HTA? Conor Teljeur, HIQA, Ireland See the presentation Introduction
The purpose of the assessment is to evaluate canagliflozin ‘Invokana’ and its use as a treatment of type 2 diabetes mellitus. Final version of the assessment was published in February 2014 Below is the documentation provided by the Joint Assessment authoring team: Canagliflozin
Replies to the comments received from the Public Consultation on the draft Project Plan from WP5 Strand B – 4th pilot
Authors’ replies to the comments received via public consultation on the WP5 Strand B Draft Project Plan on “Biodegradable stents for benign refractory esophageal stenosis".Project Plan Draft_replies_public consultation_biodegradable stents
Joint EMA-EUnetHTA press release on the publication of results of the first European collaboration between regulators and HTA organisations
Press release - Improving contribution of regulatory ARs to HTA_20140625
At the HTA 2.0 Europe conference's networking area the attendees had a unique opportunity to meet and discuss with the representatives of EUnetHTA, through the six activity stations, as well as the HTA projects of the 7th Framework Research Programme
The HTA 2.0 Europe conference conference brought the participants up-to-date on the latest developments in the interface between science and policy in European healthcare – on HTA, regulation, reimbursement, health policy, and contributing fields of research. The conference also provided many opportunities for
[embed]https://www.youtube.com/watch?list=PL5jj-ES_ud-LOTIe8QA_eAnHVrApjAa6G&v=-I18X8k-9LM[/embed] Please find all recordings of the conference embedded into this page above. Click on play and hear all sessions from 1-7 or use the playlist function in the upper left-hand corner to select between the 7 sessions: 1. Welcome and introduction 2.
The first document presents the full conference programme including session descriptions and the second contains a full list of all speakers' biographies. HTA2.0 Europe - Teaming Up for Value_Oct 30-31_Programme_session descriptions_20141024_0 Speakers biographies_final_20141027